Pub Date : 2024-10-01Epub Date: 2024-07-20DOI: 10.1016/j.deman.2024.100235
Ahmed Hasan, Almas Zafar
Gestational diabetes is a prevalent condition that affects up to 24.2 % of women in South-East Asia. A study conducted in Iran highlighted the correlation between gestational diabetes and anxiety/depression. Improvements can be made by conducting a cohort study to better establish the causality between the compounding factors of mental health and gestational diabetes. Additionally, conducting a follow-up study in a region with a higher incidence of gestational diabetes, such as South-East Asia, can broaden the geographic distribution of the available data. We must promote awareness campaigns highlighting this correlation to improve holistic healthcare strategies.
{"title":"Diabetes in pregnancy: Anxious minds precarious times","authors":"Ahmed Hasan, Almas Zafar","doi":"10.1016/j.deman.2024.100235","DOIUrl":"10.1016/j.deman.2024.100235","url":null,"abstract":"<div><p>Gestational diabetes is a prevalent condition that affects up to 24.2 % of women in South-East Asia. A study conducted in Iran highlighted the correlation between gestational diabetes and anxiety/depression. Improvements can be made by conducting a cohort study to better establish the causality between the compounding factors of mental health and gestational diabetes. Additionally, conducting a follow-up study in a region with a higher incidence of gestational diabetes, such as South-East Asia, can broaden the geographic distribution of the available data. We must promote awareness campaigns highlighting this correlation to improve holistic healthcare strategies.</p></div>","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"16 ","pages":"Article 100235"},"PeriodicalIF":1.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666970624000398/pdfft?md5=fec62aa64c34fd7b15ca81914bd6bdbf&pid=1-s2.0-S2666970624000398-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141843525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-01Epub Date: 2024-06-25DOI: 10.1016/j.deman.2024.100228
Ricko Damberg Nissen, Jesper Bo Nielsen
Background
In Denmark, the primary responsibility for treatment of patients with diabetes has shifted from hospitals to primary care. Thus, general practice has assumed responsibility for a complex and multifaceted disease. To address this situation a stratification tool to assist the nurses in primary care in their work with diabetes patients was developed.
Aim
In the present study we evaluated this stratification tool.
Method
The evaluation was based on 18 semi-structured interviews conducted with nurses employed in primary care across Denmark, and who had experience with the stratification tool. The data was subsequently analyzed by content and thematic analyses.
Results
The interviewees were generally positive towards the stratification tool. The analyses established three themes 1. Treatment, 2. Resources, and 3. Points of critique.
Conclusions
Our study indicates that a combined tool for risk stratification of patients with T2D and for subsequent risk communication is perceived as positive and supportive for quality in care. It is seen to potentially reduce the resources presently allocated to well-regulated and stable T2D patients. These resources will eventually be available for other patients. The positive reception by nurses supports that tools like the Diabetes Control Support Tool could be developed and implemented in general practice.
{"title":"Evaluation of a Support Tool for Diabetes Control in primary care – A Qualitative study with primary care staff","authors":"Ricko Damberg Nissen, Jesper Bo Nielsen","doi":"10.1016/j.deman.2024.100228","DOIUrl":"https://doi.org/10.1016/j.deman.2024.100228","url":null,"abstract":"<div><h3>Background</h3><p>In Denmark, the primary responsibility for treatment of patients with diabetes has shifted from hospitals to primary care. Thus, general practice has assumed responsibility for a complex and multifaceted disease. To address this situation a stratification tool to assist the nurses in primary care in their work with diabetes patients was developed.</p></div><div><h3>Aim</h3><p>In the present study we evaluated this stratification tool.</p></div><div><h3>Method</h3><p>The evaluation was based on 18 semi-structured interviews conducted with nurses employed in primary care across Denmark, and who had experience with the stratification tool. The data was subsequently analyzed by content and thematic analyses.</p></div><div><h3>Results</h3><p>The interviewees were generally positive towards the stratification tool. The analyses established three themes 1. Treatment, 2. Resources, and 3. Points of critique.</p></div><div><h3>Conclusions</h3><p>Our study indicates that a combined tool for risk stratification of patients with T2D and for subsequent risk communication is perceived as positive and supportive for quality in care. It is seen to potentially reduce the resources presently allocated to well-regulated and stable T2D patients. These resources will eventually be available for other patients. The positive reception by nurses supports that tools like the Diabetes Control Support Tool could be developed and implemented in general practice.</p></div>","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"16 ","pages":"Article 100228"},"PeriodicalIF":1.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666970624000337/pdfft?md5=9c4c5a22cb9a7b99acc7e735767daafd&pid=1-s2.0-S2666970624000337-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141540064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The decision to fast or not is quite complex. Personal, medical and religious matters may influence it for individuals with diabetes. However, a diagnosis of diabetes does not constitute an automatic exemption from Ramadan fasting. We aimed to evaluate the characteristics of the non-fasting cohort and explore the potential reasons during Ramadan through the global Ramadan surveys of 2020 and 2022.
Method
The Diabetes and Ramadan (DaR) Global Study is an observational retrospective survey conducted between 2020 and 2022, which included adult patients (18 and older) who fasted and those who opted not to fast. The survey captured demographic data and patient characteristics (co-morbidities, duration and type of diabetes, diabetes-related complications and medications, development of acute complications during Ramadan, hospitalisations and ER visits) for both groups.
Results
Of 12,059 patients, 1822 (14.5 %) did not fast during Ramadan; that population leaned towards females (54.6 %). They had an average age of 60.58 years (SD=12.12) with a statistically significant difference from the fasting population, averaging 54.29±11.45 (p = 0.000). Also of note was the more significant average duration of diabetes in the non-fasting cohort (12.54 years vs 9.44). There are notable regional differences in rates of fasting that ranged between 6.3 % and up to 51.2 % of patients opting not fast in certain regions (Chart 1). The risk factors that showed apparent differences of high statistical significance (p ≤ 0.001) included: long duration of diabetes of over ten years, age above 60+ years, HbA1c value over 9 %, use of insulin therapy, and being affected by one or more vascular complications (these include CKD, CVD, and diabetic foot problems).
Conclusions
Many factors and comorbidities might influence patients’ decisions when planning Ramadan fasting. The non-fasting population's demographic and clinical profiles reveal distinctive features, emphasising a need for tailored risk assessments. Furthermore, regional disparities in the decision to fast underscore the multifaceted nature of this decision-making process. The new IDF-DAR risk assessment tool can help to stratify patients’ risk during Ramadan fasting and bridge the gap among different populations and cultures.
{"title":"Characteristics of non-fasting patients with diabetes type 2 in the DAR global surveys of 2020 and 2022","authors":"Bachar Afandi , Khadija Hafidh , Rachid Malek , M Yakoob Ahmedani , Inass Shaltout , Reem Alamoudi , Zanariah Hussein , Mohamed Hassanein","doi":"10.1016/j.deman.2024.100217","DOIUrl":"https://doi.org/10.1016/j.deman.2024.100217","url":null,"abstract":"<div><h3>Introduction</h3><p>The decision to fast or not is quite complex. Personal, medical and religious matters may influence it for individuals with diabetes. However, a diagnosis of diabetes does not constitute an automatic exemption from Ramadan fasting. We aimed to evaluate the characteristics of the non-fasting cohort and explore the potential reasons during Ramadan through the global Ramadan surveys of 2020 and 2022.</p></div><div><h3>Method</h3><p>The Diabetes and Ramadan (DaR) Global Study is an observational retrospective survey conducted between 2020 and 2022, which included adult patients (18 and older) who fasted and those who opted not to fast. The survey captured demographic data and patient characteristics (co-morbidities, duration and type of diabetes, diabetes-related complications and medications, development of acute complications during Ramadan, hospitalisations and ER visits) for both groups.</p></div><div><h3>Results</h3><p>Of 12,059 patients, 1822 (14.5 %) did not fast during Ramadan; that population leaned towards females (54.6 %). They had an average age of 60.58 years (SD=12.12) with a statistically significant difference from the fasting population, averaging 54.29±11.45 (<em>p</em> = 0.000). Also of note was the more significant average duration of diabetes in the non-fasting cohort (12.54 years vs 9.44). There are notable regional differences in rates of fasting that ranged between 6.3 % and up to 51.2 % of patients opting not fast in certain regions (Chart 1). The risk factors that showed apparent differences of high statistical significance (<em>p</em> ≤ 0.001) included: long duration of diabetes of over ten years, age above 60+ years, HbA1c value over 9 %, use of insulin therapy, and being affected by one or more vascular complications (these include CKD, CVD, and diabetic foot problems).</p></div><div><h3>Conclusions</h3><p>Many factors and comorbidities might influence patients’ decisions when planning Ramadan fasting. The non-fasting population's demographic and clinical profiles reveal distinctive features, emphasising a need for tailored risk assessments. Furthermore, regional disparities in the decision to fast underscore the multifaceted nature of this decision-making process. The new IDF-DAR risk assessment tool can help to stratify patients’ risk during Ramadan fasting and bridge the gap among different populations and cultures.</p></div>","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"15 ","pages":"Article 100217"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666970624000222/pdfft?md5=4eb5e3f489f47bab3d4af0c5dbecd660&pid=1-s2.0-S2666970624000222-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140558176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mellitus diabetes is an endocrine trouble characterized by chronic high glycemia caused by a relative or absolute insulin deficiency. It is a public health problem because of its frequency associated with high morbi-mortality. The objective of this research was to determine the frequency of mellitus diabetes in under 15-year-old patients in Butembo Town.
Method
it was a cross-sectional descriptive study realized at the University Clinics of Graben from January 1st, 2017 to December 31st, 2021.
Results
Between 2017 and 2021, 3,681 children and adolescents were hospitalized at the University Clinics of the Graben Pediatrics Department. Out of them, 49 were diagnosed with mellitus diabetes, which indicates a prevalence of 1.331 %. The majority of patients were males, with high frequencies observed between the ages of 2 to 12 years. Common complaints included coma, polyurea-polydipsia, vision troubles, fever, weight loss, and growth retardation. Complications in infants and adolescents with diabetes included retinopathies, neuropathies, coma, infection, and ketoacidosis. The patients were admitted with extreme glycemia, with many suffering from hypoglycemia. Forty-three out of the 49 patients received insulin, and five of them died.
Conclusion
Mellitus diabetes in young remains a health problem in Butembo. Effective healthcare must include medical professionals, the population, and the state.
{"title":"Hospital prevalence of diabetes mellitus among under 15 children in Butembo: A retrospective study at the University Clinics of Graben","authors":"Roland Muyisa , Emile Watumwa , Apollinaire SaaSita , Judith Kithonga , Judith Malembe , Wivine Kitasuvirwa , Ghyslaine Kalivanda , Mupenzi Mumbere , Francois Mbahweka , Soly Kamwira","doi":"10.1016/j.deman.2024.100218","DOIUrl":"https://doi.org/10.1016/j.deman.2024.100218","url":null,"abstract":"<div><h3>Introduction</h3><p>Mellitus diabetes is an endocrine trouble characterized by chronic high glycemia caused by a relative or absolute insulin deficiency. It is a public health problem because of its frequency associated with high morbi-mortality. The objective of this research was to determine the frequency of mellitus diabetes in under 15-year-old patients in Butembo Town.</p></div><div><h3>Method</h3><p>it was a cross-sectional descriptive study realized at the University Clinics of Graben from January 1st, 2017 to December 31st, 2021.</p></div><div><h3>Results</h3><p>Between 2017 and 2021, 3,681 children and adolescents were hospitalized at the University Clinics of the Graben Pediatrics Department. Out of them, 49 were diagnosed with mellitus diabetes, which indicates a prevalence of 1.331 %. The majority of patients were males, with high frequencies observed between the ages of 2 to 12 years. Common complaints included coma, polyurea-polydipsia, vision troubles, fever, weight loss, and growth retardation. Complications in infants and adolescents with diabetes included retinopathies, neuropathies, coma, infection, and ketoacidosis. The patients were admitted with extreme glycemia, with many suffering from hypoglycemia. Forty-three out of the 49 patients received insulin, and five of them died.</p></div><div><h3>Conclusion</h3><p>Mellitus diabetes in young remains a health problem in Butembo. Effective healthcare must include medical professionals, the population, and the state.</p></div>","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"15 ","pages":"Article 100218"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666970624000234/pdfft?md5=3983443ffc27baa3220ce1f0574b1df0&pid=1-s2.0-S2666970624000234-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140649591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-01Epub Date: 2024-05-16DOI: 10.1016/j.deman.2024.100221
Samer Younes
Background
The rising prevalence of type 2 diabetes (T2D) in Syria emphasizes the urgent requirement for effective management approaches. The ABC goals, which include maintaining glycated hemoglobin levels below 7 %, blood pressure below 140/90 mmHg, and low-density lipoprotein cholesterol levels below 100 mg/dl, serve as crucial benchmarks for managing T2D and its associated comorbidities.
Methods
In this cross-sectional study, the achievement of ABC goals was retrospectively examined among 681 clinically diagnosed T2D patients (not on Insulin) who participated in a six-year online lifestyle intervention program for diabetes management at the Freedom from Diabetes Clinic in Syria between January 2016 and December 2022.
Results
Out of the participants, 152 (22.3 %) successfully achieved all three ABC goals, while 306 (45.0 %) and 183 (26.9 %) achieved two or one goal(s) respectively. The factors influencing the attainment of all three ABC goals revealed a significant association with older age (>50 years), lower body mass index (<25 kg/m2), and lower insulin resistance (Homeostatic Model Assessment of Insulin Resistance < 2.5). Furthermore, patients who successfully achieved all three ABC goals exhibited lower insulin resistance, improved lipid profiles, and higher insulin sensitivity and beta cell function.
Conclusion
This study offers new insights into the relationship between insulin resistance/sensitivity and the achievement of ABC goals in the Syrian population with T2D, underscoring the necessity for tailored strategies to enhance comprehensive diabetes management.
{"title":"The correlation of ABC goal attainment with insulin resistance/sensitivity in Syrian type 2 diabetes patients","authors":"Samer Younes","doi":"10.1016/j.deman.2024.100221","DOIUrl":"10.1016/j.deman.2024.100221","url":null,"abstract":"<div><h3>Background</h3><p>The rising prevalence of type 2 diabetes (T2D) in Syria emphasizes the urgent requirement for effective management approaches. The ABC goals, which include maintaining glycated hemoglobin levels below 7 %, blood pressure below 140/90 mmHg, and low-density lipoprotein cholesterol levels below 100 mg/dl, serve as crucial benchmarks for managing T2D and its associated comorbidities.</p></div><div><h3>Methods</h3><p>In this cross-sectional study, the achievement of ABC goals was retrospectively examined among 681 clinically diagnosed T2D patients (not on Insulin) who participated in a six-year online lifestyle intervention program for diabetes management at the Freedom from Diabetes Clinic in Syria between January 2016 and December 2022.</p></div><div><h3>Results</h3><p>Out of the participants, 152 (22.3 %) successfully achieved all three ABC goals, while 306 (45.0 %) and 183 (26.9 %) achieved two or one goal(s) respectively. The factors influencing the attainment of all three ABC goals revealed a significant association with older age (>50 years), lower body mass index (<25 kg/m2), and lower insulin resistance (Homeostatic Model Assessment of Insulin Resistance < 2.5). Furthermore, patients who successfully achieved all three ABC goals exhibited lower insulin resistance, improved lipid profiles, and higher insulin sensitivity and beta cell function.</p></div><div><h3>Conclusion</h3><p>This study offers new insights into the relationship between insulin resistance/sensitivity and the achievement of ABC goals in the Syrian population with T2D, underscoring the necessity for tailored strategies to enhance comprehensive diabetes management.</p></div>","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"15 ","pages":"Article 100221"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266697062400026X/pdfft?md5=f5fd82ac6f31fec02870d126545664a8&pid=1-s2.0-S266697062400026X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141025367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Diabetes and tobacco use are well-established risk factors for stroke. However, the intersection of prediabetes, tobacco use, and stroke among young individuals remains underexplored. This study aims to investigate the association between pre-diabetes and stroke risk in young tobacco users.
Methods
Using the National Inpatient Sample (2019) and relevant ICD-10 codes, we identified young patients with tobacco use disorder and pre-diabetes. Regression analysis considered risk factors (gender, demographics, income, comorbidities) to assess stroke odds.
Results
Among 1,017,540 stroke hospitalizations, 1.9 % were pre-diabetic. Pre-diabetics were often older (median age 36 vs. 31), male (59.4 %), Black (33.8 %), and Hispanic (12.2 %), with higher rates of comorbidities, including drug abuse, alcohol abuse, COPD, and CKD (p < 0.001). They also exhibited higher rates of stroke events (1.9 % vs. 0.5 %, p < 0.001). Multivariable analysis after adjusting for confounders, young metabolically healthy smokers with pre-diabetes had a higher risk of stroke (aOR 3.31, 95 % CI [1.67–6.55], p < 0.001).
Conclusion
Prediabetes could potentially triple stroke risk in young tobacco smokers. Prospective research is warranted to explore the causal association between pre-diabetes and stroke in the setting of tobacco use.
{"title":"Association of prediabetes with stroke in young metabolically healthy tobacco users: A population-based analysis","authors":"Advait Vasavada , Arankesh Mahadevan , Manisha Jain , Subramanian Gnanaguruparan , Rupak Desai","doi":"10.1016/j.deman.2024.100210","DOIUrl":"https://doi.org/10.1016/j.deman.2024.100210","url":null,"abstract":"<div><h3>Background</h3><p>Diabetes and tobacco use are well-established risk factors for stroke. However, the intersection of prediabetes, tobacco use, and stroke among young individuals remains underexplored. This study aims to investigate the association between pre-diabetes and stroke risk in young tobacco users.</p></div><div><h3>Methods</h3><p>Using the National Inpatient Sample (2019) and relevant ICD-10 codes, we identified young patients with tobacco use disorder and pre-diabetes. Regression analysis considered risk factors (gender, demographics, income, comorbidities) to assess stroke odds.</p></div><div><h3>Results</h3><p>Among 1,017,540 stroke hospitalizations, 1.9 % were pre-diabetic. Pre-diabetics were often older (median age 36 vs. 31), male (59.4 %), Black (33.8 %), and Hispanic (12.2 %), with higher rates of comorbidities, including drug abuse, alcohol abuse, COPD, and CKD (<em>p</em> < 0.001). They also exhibited higher rates of stroke events (1.9 % vs. 0.5 %, <em>p</em> < 0.001). Multivariable analysis after adjusting for confounders, young metabolically healthy smokers with pre-diabetes had a higher risk of stroke (aOR 3.31, 95 % CI [1.67–6.55], <em>p</em> < 0.001).</p></div><div><h3>Conclusion</h3><p>Prediabetes could potentially triple stroke risk in young tobacco smokers. Prospective research is warranted to explore the causal association between pre-diabetes and stroke in the setting of tobacco use.</p></div>","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"15 ","pages":"Article 100210"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666970624000155/pdfft?md5=a95efa544ec5b5f638e4cf57c191dc00&pid=1-s2.0-S2666970624000155-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140191303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
There remains a paucity of research comparing the diagnostic and therapeutic outcomes between Magnetic Resonance Imaging (MRI) and x-ray modalities for Charcot neuro-osteoarthropathy CNO. This retrospective study investigates the use of offloading devices, duration of offloading and final footwear outcomes dependent on imaging at diagnosis.
Methods
Medical records from a secondary hospital high-risk foot clinic in Perth, Western Australia, were systematically reviewed. Data collected included baseline medical history, location of CNO, Eichenholtz stage or Chantelau and Grutznel grade at diagnosis, type and duration of offloading, and final footwear outcomes.
Results
Twenty-eight patients met the inclusion criteria. All had diabetes and peripheral neuropathy. All patients received either an MRI (43%) or x-ray (57%) to confirm the diagnosis of active CNO. Five (17.9%) patients who were diagnosed on MRI had grade 0 CNO whilst 23 (82.1%) patients who were diagnosed on x-ray had stage 1 CNO. No statistical significance was found between the type and duration of offloading, resolution of CNO, footwear and transtibial amputation (TTA) outcomes across those diagnosed with MRI or x-ray.
Conclusion
No statistical significance in patient outcomes was found between those diagnosed with grade 0 on MRI and those diagnosed with stage 1 on x-ray.
背景目前仍很少有研究比较磁共振成像(MRI)和X射线模式对Charcot神经性骨关节病CNO的诊断和治疗效果。这项回顾性研究调查了诊断时使用的卸载装置、卸载持续时间和最终的鞋类治疗效果与成像结果之间的关系。方法对西澳大利亚州珀斯市一家二级医院高风险足部诊所的医疗记录进行了系统回顾。收集的数据包括基线病史、CNO位置、诊断时的Eichenholtz分期或Chantelau和Grutznel分级、卸载类型和持续时间以及最终的鞋类治疗效果。所有患者均患有糖尿病和周围神经病变。所有患者均接受了核磁共振成像(43%)或X光检查(57%),以确诊为活动性CNO。5名(17.9%)通过核磁共振成像确诊的患者为 0 级 CNO,23 名(82.1%)通过 X 光确诊的患者为 1 期 CNO。结论 MRI 诊断为 0 级的患者与 X 光诊断为 1 级的患者在治疗效果上没有统计学意义。
{"title":"Early diagnosis of Charcot neuro-osteoarthropathy using MRI and its effect on patient outcomes: A seven-year retrospective audit","authors":"Laksh Lukkhoo , Sharlene Vu , Joanna Scheepers , Deborah Schoen","doi":"10.1016/j.deman.2024.100208","DOIUrl":"https://doi.org/10.1016/j.deman.2024.100208","url":null,"abstract":"<div><h3>Background</h3><p>There remains a paucity of research comparing the diagnostic and therapeutic outcomes between Magnetic Resonance Imaging (MRI) and x-ray modalities for Charcot neuro-osteoarthropathy CNO. This retrospective study investigates the use of offloading devices, duration of offloading and final footwear outcomes dependent on imaging at diagnosis.</p></div><div><h3>Methods</h3><p>Medical records from a secondary hospital high-risk foot clinic in Perth, Western Australia, were systematically reviewed. Data collected included baseline medical history, location of CNO, Eichenholtz stage or Chantelau and Grutznel grade at diagnosis, type and duration of offloading, and final footwear outcomes.</p></div><div><h3>Results</h3><p>Twenty-eight patients met the inclusion criteria. All had diabetes and peripheral neuropathy. All patients received either an MRI (43%) or x-ray (57%) to confirm the diagnosis of active CNO. Five (17.9%) patients who were diagnosed on MRI had grade 0 CNO whilst 23 (82.1%) patients who were diagnosed on x-ray had stage 1 CNO. No statistical significance was found between the type and duration of offloading, resolution of CNO, footwear and transtibial amputation (TTA) outcomes across those diagnosed with MRI or x-ray.</p></div><div><h3>Conclusion</h3><p>No statistical significance in patient outcomes was found between those diagnosed with grade 0 on MRI and those diagnosed with stage 1 on x-ray.</p></div>","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"15 ","pages":"Article 100208"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666970624000131/pdfft?md5=2b43b95910ef45809f0883f0f651baf3&pid=1-s2.0-S2666970624000131-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140180047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-01Epub Date: 2024-04-21DOI: 10.1016/j.deman.2024.100219
Sathish Thirunavukkarasu
{"title":"Epidemiology of isolated impaired fasting glucose among Asian Indians","authors":"Sathish Thirunavukkarasu","doi":"10.1016/j.deman.2024.100219","DOIUrl":"https://doi.org/10.1016/j.deman.2024.100219","url":null,"abstract":"","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"15 ","pages":"Article 100219"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666970624000246/pdfft?md5=0b764abe89c0fb35014317b553ad8f8a&pid=1-s2.0-S2666970624000246-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140637941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-01Epub Date: 2024-03-16DOI: 10.1016/j.deman.2024.100216
Jennifer Adjepong Agyekum , Kwame Yeboah
Background
Type 2 diabetes (T2DM) is associated with high burden of atherosclerotic macrovascular disease which could be diagnosed with ankle-brachial index (ABI). Phase angle (PhA) from bioelectric impedance analysis is associated with the development of cardiovascular diseases. We investigated the association between low ABI and phase angle in T2DM patients in Ghana.
Method
In a cross-sectional study, 462 T2DM patients were systematically recruited for the study. ABI was measured using an 8 Hz continuous Doppler and ABI≤0.9 was considered to be low ABI. PhA was obtained from resistance and reactance from Bioelectric impedance analysis.
Results
The prevalence of low ABI was 16 % in the study population. T2DM patients with low ABI have decreased PhA (7.5 ± 1.9 vs 8.3 ± 2.2 units, p = 0.004) compared to those with normal ABI. An increase in phase angle by 1° was associated with a decrease in odds of having low ABI in unadjusted [OR (95 % CI) = 0.79 (0.48 – 0.95), p = 0.007] and adjusted models [0.88 (0.43 – 0.98), p = 0.036].
Conclusion
The prevalence of low ABI in T2DM patients in this study was 16 %. Also, PhA was lower in patients with low ABI compared to those with normal ABI.
背景2型糖尿病(T2DM)与动脉粥样硬化性大血管疾病的高负担相关,而动脉粥样硬化性大血管疾病可通过踝肱指数(ABI)进行诊断。生物电阻抗分析得出的相位角(PhA)与心血管疾病的发展有关。我们调查了加纳 T2DM 患者低 ABI 与相位角之间的关系。使用 8 赫兹连续多普勒测量 ABI,ABI≤0.9 为低 ABI。从生物电阻抗分析的电阻和电抗中获得 PhA。与正常 ABI 患者相比,低 ABI T2DM 患者的 PhA 值降低(7.5 ± 1.9 vs 8.3 ± 2.2 单位,p = 0.004)。在未调整模型[OR (95 % CI) = 0.79 (0.48 - 0.95),p = 0.007]和调整模型[0.88 (0.43 - 0.98),p = 0.036]中,相位角增加 1°与低 ABI 的几率降低有关。此外,与正常 ABI 患者相比,低 ABI 患者的 PhA 值较低。
{"title":"Phase angle associated is with low ankle-brachial index in type 2 diabetes patients in Ghana","authors":"Jennifer Adjepong Agyekum , Kwame Yeboah","doi":"10.1016/j.deman.2024.100216","DOIUrl":"https://doi.org/10.1016/j.deman.2024.100216","url":null,"abstract":"<div><h3>Background</h3><p>Type 2 diabetes (T2DM) is associated with high burden of atherosclerotic macrovascular disease which could be diagnosed with ankle-brachial index (ABI). Phase angle (PhA) from bioelectric impedance analysis is associated with the development of cardiovascular diseases. We investigated the association between low ABI and phase angle in T2DM patients in Ghana.</p></div><div><h3>Method</h3><p>In a cross-sectional study, 462 T2DM patients were systematically recruited for the study. ABI was measured using an 8 Hz continuous Doppler and ABI≤0.9 was considered to be low ABI. PhA was obtained from resistance and reactance from Bioelectric impedance analysis.</p></div><div><h3>Results</h3><p>The prevalence of low ABI was 16 % in the study population. T2DM patients with low ABI have decreased PhA (7.5 ± 1.9 vs 8.3 ± 2.2 units, <em>p</em> = 0.004) compared to those with normal ABI. An increase in phase angle by 1° was associated with a decrease in odds of having low ABI in unadjusted [OR (95 % CI) = 0.79 (0.48 – 0.95), <em>p</em> = 0.007] and adjusted models [0.88 (0.43 – 0.98), <em>p</em> = 0.036].</p></div><div><h3>Conclusion</h3><p>The prevalence of low ABI in T2DM patients in this study was 16 %. Also, PhA was lower in patients with low ABI compared to those with normal ABI.</p></div>","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"15 ","pages":"Article 100216"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666970624000210/pdfft?md5=20ec669293ad684e8b07be6d669947a6&pid=1-s2.0-S2666970624000210-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140180046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-01Epub Date: 2024-01-09DOI: 10.1016/j.deman.2024.100196
Katarina Q. Watson , Akshaya Kannan , Nasim C. Sobhani
Aims
To compare obstetric and neonatal outcomes in patients with type 2 diabetes mellitus (T2DM) who had scheduled delivery at full term (≥ 39 0/7 weeks) compared to early term (37 0/7 – 38 6/7 weeks) for T2DM indications.
Methods
This was a retrospective cohort study that included all singletons with T2DM with a scheduled delivery at a single tertiary care center between January 2008 and March 2022. Outcomes were compared using Fisher's exact test.
Results
107 singleton pregnancies were included. There was no significant difference in primary cesarean delivery between the two groups. The early term group had significantly higher rates of NICU admission compared to the term group (52% vs 32%, p = 0.05, OR 2.3, 95% CI 1.0–5.0), a finding that remained statistically significant on adjusted analysis (adjusted OR 2.81, 95% CI 1.04–7.58).
Conclusions
In singleton pregnancies undergoing scheduled delivery for T2DM-specific indications, early term deliveries were associated with significantly increased odds of NICU admission when compared to term deliveries, even after adjusting for surrogate markers of glycemic control. These findings suggest that early term delivery contributes to risk of NICU admission, rather than the indication for delivery itself. These findings should be replicated in a larger cohort.
{"title":"Impact of timing of delivery for type 2 diabetes on perinatal outcomes","authors":"Katarina Q. Watson , Akshaya Kannan , Nasim C. Sobhani","doi":"10.1016/j.deman.2024.100196","DOIUrl":"10.1016/j.deman.2024.100196","url":null,"abstract":"<div><h3>Aims</h3><p>To compare obstetric and neonatal outcomes in patients with type 2 diabetes mellitus (T2DM) who had scheduled delivery at full term (≥ 39 0/7 weeks) compared to early term (37 0/7 – 38 6/7 weeks) for T2DM indications.</p></div><div><h3>Methods</h3><p>This was a retrospective cohort study that included all singletons with T2DM with a scheduled delivery at a single tertiary care center between January 2008 and March 2022. Outcomes were compared using Fisher's exact test.</p></div><div><h3>Results</h3><p>107 singleton pregnancies were included. There was no significant difference in primary cesarean delivery between the two groups. The early term group had significantly higher rates of NICU admission compared to the term group (52% vs 32%, <em>p</em> = 0.05, OR 2.3, 95% CI 1.0–5.0), a finding that remained statistically significant on adjusted analysis (adjusted OR 2.81, 95% CI 1.04–7.58).</p></div><div><h3>Conclusions</h3><p>In singleton pregnancies undergoing scheduled delivery for T2DM-specific indications, early term deliveries were associated with significantly increased odds of NICU admission when compared to term deliveries, even after adjusting for surrogate markers of glycemic control. These findings suggest that early term delivery contributes to risk of NICU admission, rather than the indication for delivery itself. These findings should be replicated in a larger cohort.</p></div>","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"14 ","pages":"Article 100196"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666970624000015/pdfft?md5=54b12b6dc4f2e8f16add805a991de305&pid=1-s2.0-S2666970624000015-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139458272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}